Promotion of Well-being of Young Adult Brain Cancer Survivors

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness of an Internet-based, behavioral activation intervention to promote well-being in a young adult survivors of childhood brain tumor.

Clinical Trial Description

Participants will be recruited through the Children's Brain Tumor Foundation who will share the study announcement with their young adult members and social media. Eligible participants will complete a baseline battery survey via Qualtrics. The investigators will recruit 120 participants. The survey will take approximately 30 minutes to complete. Participants will be randomly assigned to an experimental group or control group. The experimental group will take an Internet-based behavioral activation intervention. The intervention has four modules and will be administered via Qualtrics. A link to each module will be sent to the participants via e-mail. Participants will have one week to complete each module. Once a participant completes a module, the next module link will be sent after 3 days. A reminder will be sent at 7 days and 10 days until the module is complete. Each module will take approximately 30 minutes to complete. The experimental group may continue to receive services as usual from the Children's Brain Tumor Foundation. The control group will continue to receive services as usual from the Children's Brain Tumor Foundation. The control group will have an opportunity to take the intervention once data collection is complete. Both groups will be asked to complete a battery of surveys at the end of the intervention and intermittently over a 3-month period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03871686
Study type	Interventional
Source	University of Wisconsin, Madison
Contact
Status	Completed
Phase	N/A
Start date	February 13, 2019
Completion date	May 19, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03936465` - Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer	Phase 1
Recruiting	`NCT04738162` - Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors	Phase 2
Not yet recruiting	`NCT06093165` - RE-irradiation of Diffuse MIdline Glioma paTients	N/A
Recruiting	`NCT05298995` - GD2-CAR T Cells for Pediatric Brain Tumours	Phase 1
Not yet recruiting	`NCT05553899` - PET-MRI in Paediatric Brain Tumours	N/A
Recruiting	`NCT05709522` - Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients
Recruiting	`NCT04722237` - Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing	N/A
Recruiting	`NCT06309251` - Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
Recruiting	`NCT04670016` - HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
Active, not recruiting	`NCT03086421` - Social Emotional Development in Young Children With Cancer
Active, not recruiting	`NCT03361033` - Components of Social Functioning in Survivors of Pediatric Brain Tumors
Active, not recruiting	`NCT04525014` - RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors	Phase 1
Recruiting	`NCT05672043` - Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Withdrawn	`NCT04019470` - Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors
Active, not recruiting	`NCT04023669` - Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors	Phase 1
Suspended	`NCT05169944` - Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors	Phase 1